Nasopharyngeal Type-I Interferon for Immediately Available Prophylaxis Against Emerging Respiratory Viral Infections

Nasopharyngeal Type-I Interferon for Immediately Available Prophylaxis Against Emerging Respiratory Viral Infections

In addition to SARS-CoV-2 and its variants, emerging viruses that cause respiratory viral infections will continue to arise. Increasing evidence suggests a delayed, possibly suppressed, type 1 interferon (IFN-I) response occurs early during COVID-19 and other viral respiratory infections such as SAR...

Full description

Bibliographic Details
Main Authors: Amos C. Lee, Yunjin Jeong, Sumin Lee, Haewook Jang, Allen Zheng, Sunghoon Kwon, John E. Repine
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Immunology
Subjects:
prophylaxis
emerging respiratory viral infection
type-I interferon
nasopharyngeal
post-pandemic
coronavirus
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.660298/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.660298/full

Similar Items